Anti-CD20 Antibodies for Treatment of SLE-PAH

Clinical trial NCT05828147 · UNKNOWN

Trial details

NCT number: NCT05828147
Sponsor: Chinese SLE Treatment And Research Group
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus Pulmonary Arterial Hypertension

Start date: 2023-05-25
Primary completion: 2025-03-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.